PortfoliosLab logo

Artelo Biosciences, Inc. (ARTL)

Equity · Currency in USD · Last updated Mar 27, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in Artelo Biosciences, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $348 for a total return of roughly -96.52%. All prices are adjusted for splits and dividends.

ARTL (Artelo Biosciences, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ARTL

Artelo Biosciences, Inc.


Artelo Biosciences, Inc. had a return of -27.68% year-to-date (YTD) and -68.01% in the last 12 months. Over the past 10 years, Artelo Biosciences, Inc. had an annualized return of -54.85%, while the S&P 500 had an annualized return of 8.54%, indicating that Artelo Biosciences, Inc. did not perform as well as the benchmark.

1 month-31.48%-0.66%
6 months-39.60%5.67%
1 year-68.01%-10.89%
5 years (annualized)-62.35%8.93%
10 years (annualized)-54.85%8.54%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Artelo Biosciences, Inc. Sharpe ratio is -0.78. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

ARTL (Artelo Biosciences, Inc.)
Benchmark (^GSPC)

Dividend History

Artelo Biosciences, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

ARTL (Artelo Biosciences, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Artelo Biosciences, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Artelo Biosciences, Inc. is 99.35%, recorded on Mar 24, 2023. The portfolio has not recovered from it yet.



To Bottom


To Recover



-99.35%Jan 19, 20181054Mar 24, 2023
-20%Dec 11, 20172Dec 21, 20171Jan 2, 20183

Volatility Chart

Current Artelo Biosciences, Inc. volatility is 56.26%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

ARTL (Artelo Biosciences, Inc.)
Benchmark (^GSPC)